P2RX7 and depressive symptom measurement: Preclinical studies show that P2X7 receptor knockout in microglia prevents stress-induced depressive and anxiety-like behaviours, while P2X7R agonists induce such behaviours, highlighting microglial P2X7R as a potential therapeutic target for depression and anxiety [83].